hotspot -WSS

hotspot

author：hotspot 2025-08-25 08:45:36 - browse：9

In a surprise move, the Food and Drug Administration has called for a meeting of outside advisers to discuss whether an Alzheimer’s drug from Eli Lilly should be approved, even as many outsiders expected the medicine to receive regulatory clearance this month.

The drug, donanemab, succeeded in its Phase 3 trial, resulting in a 35% slowing of Alzheimer’s disease progression versus placebo. But Lilly on Friday said that the FDA expects to call a meeting of an advisory committee to review the trial, saying that the agency had told the company “it wants to further understand topics related to evaluating the safety and efficacy of donanemab, including the safety results in donanemab-treated patients and the efficacy implications of the unique trial design” of the study.

A date for the meeting has not been set yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： NIH nominee Bertagnolli will get October confirmation hearing

entertainment

WSS

NIH nominee Bertagnolli will get October confirmation hearing

House transparency, PBM reform bill gains bipartisan support

STAT Executive Editor Rick Berke on STAT's 8th birthday

FDA approves Recor Medical high blood pressure device

10 million people disenrolled from Medicaid over past six months

White House calls on federal agencies to crack down on AI abuses

knowledge

hotspot

focus

Trump demands the U.S. pay no more for drugs than other countries … again

The new shift in health care is toward less care

DIEP, the 'gold standard' of breast reconstruction, is under threat

More doctors should go into startup world

In age of alternative facts, a scholarly course on calling out crap

HPV cancer vaccine study demonstrates efficacy

The cancer drug shortage isn’t new — and neither are the solutions

The 10 drugs up first for Medicare price negotiation

Alkermes shareholders re

What drug price negotiations mean for Medicare Part D

focus

Removing probiotics from the NICU could threaten preemies' health

How to protect patients from sexual assault

What American doctors can learn from their Israeli counterparts

HPV cancer vaccine study demonstrates efficacy

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

HPV cancer vaccine study demonstrates efficacy

entertainment

leisure time

leisure time

leisure time